This is a preview of subscription content, log in via an institution to check access.
Reference
Garcia A, et al. Safety of abiraterone in metastatic castration resistant prostate cancer in clinical practice. European Journal of Hospital Pharmacy - Science and Practice 23 (Suppl. 1): A236 abstr. PS-051, Mar 2016. Available from: URL: http://doi.org/10.1136/ejhpharm-2016-000875.535 [abstract] - Spain
Rights and permissions
About this article
Cite this article
Abiraterone. Reactions Weekly 1640, 15 (2017). https://doi.org/10.1007/s40278-017-26568-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-26568-8